image
Haemonetics Corporation HAE
Healthcare - Medical - Instruments & Supplies - NYSE - US
Watchlist
$ 89.22
-1.69 %
$ 4.48 B
Market Cap
37.02
P/E
INCOME STATEMENT
1.31 B REVENUE
12.01%
Growth Rates
1Year 12.01%
3Years 14.57%
5Years 6.23%
7Years 5.73%
10Years 3.38%
165 M OPERATING INCOME
5.67%
Growth Rates
1Year 5.67%
3Years 41.69%
5Years 14.56%
7Years 39.94%
10Years 13.29%
118 M NET INCOME
1.87%
Growth Rates
1Year 1.87%
3Years 13.94%
5Years 16.40%
7Years 30.59%
10Years 12.83%
EFFICIENCY
Earnings Waterfall Haemonetics Corporation
image
Revenue 1.31 B
Cost Of Revenue 633 M
Gross Profit 677 M
Operating Expenses 527 M
Operating Income 165 M
Other Expenses 47.3 M
Net Income 118 M

Income Statement

Millions
Mar-2024 Apr-2023 Apr-2022 Apr-2021 Mar-2020 Mar-2019 Mar-2018 Apr-2017 Apr-2016 Mar-2015 Mar-2014 Mar-2013 Mar-2012 Apr-2011 Apr-2010 Mar-2009 Mar-2008 Mar-2007 Apr-2006 Apr-2005 Apr-2004 Mar-2003 Mar-2002 Mar-2001 Apr-2000 Apr-1999 Mar-1998 Mar-1997 Mar-1996 Mar-1995 Mar-1994 Mar-1993 Mar-1992 Mar-1991
REVENUE
Revenue 1 309.1 1 168.7 993.2 870.5 988.5 967.6 903.9 886.1 909.7 910.4 938.5 892.0 727.8 676.7 645.4 597.9 516.4 449.6 419.7 383.6 364.2 337.0 320.0 293.9 277.9 282.1 285.8 309.8 278.2 262.4 248.4 216.3 176.4 157.3
GROSS PROFIT
Cost Of Revenue 632.5 553.6 487.7 472.6 504.0 550.0 492.0 507.6 503.8 476.0 470.1 463.9 358.6 321.5 307.9 289.7 258.7 222.3 199.2 185.7 192.1 182.3 165.1 126.9 121.7 124.0 127.1 137.8 110.5 103.9 94.2 88.8 78.5 0
Gross Profit 676.5 615.1 505.5 397.8 484.5 417.5 411.9 378.5 405.9 434.4 468.4 428.1 369.2 355.2 337.5 308.2 257.7 227.3 220.5 197.9 172.1 154.7 154.8 166.9 156.2 158.1 158.7 172.0 167.7 158.5 154.2 127.5 97.9 157.3
OPERATING INCOME
Operating Expenses 526.7 459.1 433.8 339.9 330.6 334.0 355.8 339.3 369.5 393.9 421.0 367.4 282.1 244.7 240.9 222.6 187.4 155.5 121.5 137.9 126.2 117.2 108.4 110.4 122.6 126.4 127.7 123.6 113.4 106.1 102.4 85.7 68.0 0
Selling, General and Administrative Expenses 431.8 376.7 339.6 274.2 299.7 298.3 316.5 301.7 324.0 339.7 366.8 318.8 245.3 213.9 214.5 198.7 163.1 137.1 121.4 118.0 108.5 97.7 88.9 86.7 82.8 86.7 86.9 92.3 81.8 75.7 75.9 77.2 61.0 0
Research and Development Expenses 54.4 50.1 46.8 32.9 30.9 35.7 39.2 37.6 45.6 54.2 54.2 48.6 36.8 32.7 26.4 23.9 24.3 23.9 26.5 20.0 17.8 19.5 19.5 19.0 14.9 15.1 17.9 19.0 18.5 16.7 15.8 0 0 0
Operating Income 164.9 156.0 80.8 58.0 153.9 83.5 56.2 (19.4) (44.0) 40.5 47.3 56.4 88.8 110.5 83.3 85.6 70.3 62.7 99.0 59.9 45.9 37.5 36.4 13.4 33.6 31.7 31.0 48.4 54.3 52.4 51.8 41.8 29.9 157.3
PRE-TAX INCOME
Interest Income Expense 13.0 14.6 17.1 16.8 16.2 9.9 4.5 8.1 9.5 9.4 10.9 6.5 (54.6) 6 K 0.7 64 K (9.0) 97 K (37.0) 24 K (0.9) (3.5) 13.6 59.4 13.1 (5.9) 74.9 (6.3) (4.1) (2.1) (1.7) 1.6 1.6 0
Total Other Income (13.0) (14.6) (17.1) 14.9 (16.2) (9.9) 3.5 (8.1) (97.1) (9.4) (10.9) (6.5) 0.7 (0.5) (2.0) (0.6) 7.0 9.6 7.9 (0.1) 65 K 1.1 2.1 3.9 3.3 1.0 (26.5) 2.3 0.9 100 K (1.0) (1.8) (2.2) (157.3)
Pre-Tax Income 151.9 141.4 63.6 72.9 87.2 73.6 59.6 (27.5) (53.5) 31.2 36.4 49.9 89.5 110.1 81.3 85.0 77.3 72.3 106.9 59.8 45.8 38.6 38.5 17.3 27.3 32.6 4.5 50.7 55.2 52.5 50.8 40.0 27.7 0
NET INCOME
Tax Provision 34.3 26.0 20.3 (6.6) 10.6 18.6 14.1 (1.2) 2.2 14.3 1.3 11.1 22.6 30.1 22.9 25.7 25.3 23.2 37.8 20.2 16.5 10.2 10.8 10.1 8.5 11.4 3.9 17.7 19.3 18.9 19.3 15.2 9.7 0
Net Income 117.6 115.4 43.4 79.5 76.5 55.0 45.6 (26.3) (55.6) 16.9 35.1 38.8 66.9 80.0 58.4 59.3 52.0 49.1 69.1 39.6 29.3 28.4 30.0 7.2 19.0 21.1 (24.8) 33.0 35.9 33.6 31.5 24.8 18.0 0
EPS 2.32 2.27 0.85 1.57 1.51 1.07 0.86 0.51 1.09 0.33 0.68 0.76 1.3 1.59 1.15 1.17 1 0.92 1.29 0.77 0.6 0.57 0.57 0.14 0.3 0.39 0.47 0.61 0.66 0.61 0.56 0.45 0.33 0.26